Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) is a $1.0B biotechnology company trading at $15.45. Figures from SEC EDGAR and market feeds; updated 2026-09-05 00:04 UTC.
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) is a $1.0B biotechnology company trading at $15.45. Figures from SEC EDGAR and market feeds; updated 2026-09-05 00:04 UTC.
| Quote | |
| Price | $15.45 |
| Market cap | $1.0B |
| Volume | 2.05M shares |
| Valuation | |
| Price/book | 4.33× |
| Return on equity | -16.57% |
Monte Rosa Therapeutics, Inc. is a biotechnology company, listed on NASDAQ as GLUE.
GLUE trades at $15.45, as of 2026-09-05.
Monte Rosa Therapeutics, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-11. All filings link to their SEC EDGAR originals above.
SEC EDGAR filings and public market data feeds, fetched 2026-09-05 00:04 UTC. This page is also available as JSON at /api/data?ticker=GLUE and is emitted with FAQPage structured data for machine reading.
Charts, 10-year financials, peer comparison, screening and portfolio tracking for GLUE and 5,000+ tickers.
Create a free account — keep GLUEGET /api/data?ticker=GLUE
This page as JSON via rel="alternate" · REST API docs · MCP server (59 tools) · llms.txt